Global Marine Biotechnology Industry

News provided by

Jan 09, 2014, 06:19 ET

NEW YORK, Jan. 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Marine Biotechnology Industry
http://www.reportlinker.com/p080467/Global-Marine-Biotechnology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This report analyzes the worldwide markets for Marine Biotechnology in US$ Million.

The Global market is further analyzed by the following Product Segments:
Marine Biomaterials,
Marine Bioactive Substances,
and Others.

Major End-Use Applications also analyzed for the global market include
Industrial Products,
Health Care/Biotechnology,
Consumer Products,
Public Services & Infrastructure,
and Others.

The report provides separate comprehensive analytics for the
US,
Canada,
Japan,
Europe,
Asia-Pacific,
and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 99 companies including many key and niche players such as -
Aker BioMarine AS
Aqua Bio Technology ASA
Aquapharm Biodiscovery Ltd.
CP Kelco
Cyanotech Corp.
Nutrex Hawaii

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
By Product Segment I-3
Biomaterials I-3
Bioactive Substances I-3
Others I-3
By End-Use Application I-3
Industrial Products I-3
Health Care/Biotechnology I-4
Consumer Products I-4
Public Services and Infrastructure I-4
Others I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY DYNAMICS II-1
A Quick Primer II-1
Marine Biotechnology: A Science to Address Global Challenges II-2
Current and Future Analysis II-2
Economic Uncertainty Affects Marine Biotechnology Market II-4
Biotechnology Market: Uncertain Economy Hits R&D Funding II-5
Noteworthy Trends & Issues II-5
Medical, Food and Cosmetic Sectors Garner Research Dollars II-5
Health-Promoting Benefits of Marine Algal Proteins II-6
Sea Anemone Toxins: Opportunities for Pharma & Agricultural
Sectors II-6
Marine Worm: Potential Role in Medical Applications II-6
Coral Reefs Offer Abundant Opportunities II-7

Marine Microalgae: Promising Potential in Varied Industries II-7
Commercially Cultivated Marine Microalgae Species and their
Applications II-8
Major Applications of Marine Microalgae Biomass or their
Extracts II-8
Polysaccharides from Marine Microalgae Holds Tremendous
Potential II-9
Select Marine Microalgae Species Producing Polysaccharides II-9
Carotenoids of Marine Origin: Key Applications II-10
Major Commercially Available Carotenoids II-10
Rising Demand for HVAB's: Threat to Marine Biodiversity? II-11
Marine Ingredients for Bonding Applications: A Research Focus II-11
Biopharmaceutical Companies Shift towards Marine Natural
Products II-11
Technology Advancements Aid Research Activities II-12
Partnerships: Vital for Development of Marine Biotechnology
Research II-12
Megaprojects Hold Significance for Marine Biotechnology
Development II-14
Lack of R&D Investment in Marine Biotech: A Challenge II-14
Preserving Marine Ecology: A Prime Concern II-15

2. A REVIEW OF END-USE MARKETS/APPLICATIONS II-16
Marine Biotechnology for Sustainable Production of Healthy
Food Products II-16
Table 1: World Fisheries & Aquaculture Market (2011):
Breakdown of Production (in Million Tonnes) by Capture
Fisheries and Aquaculture (includes corresponding
Graph/Chart) II-16

Table 2: World Fisheries & Aquaculture Market (2011):
Breakdown of Production (in Million Tonnes) by Human
Consumption and Non-Food Uses (includes corresponding
Graph/Chart) II-17
Marine Resources as Functional Food Ingredients II-17
Health Benefits of Few Marine-derived Functional Food
Ingredients II-19
Marine-Derived Nutraceuticals II-19
Major Marine Nutraceutical Products: A Glance II-20
Global Omega-3 Ingredients Market - A Review II-21
Table 3: World Omega-3 Dietary Supplements Market (2012):
Percentage Share Breakdown of Volume Sales by Geographic

Region - North America, Europe, Asia-Pacific, and Rest of
World (includes corresponding Graph/Chart) II-21
Marine Biotechnology for Energy Supply II-22
Feasibility of Using Algae for Biofuel Production II-23
Marine Organisms in Cosmetics Industry II-23
Marine Ingredients in Cosmetics Industry II-23
Cosmetics Industry: Focus Shifts to Sustainable Sourcing of
Marine Ingredients II-24
Marine Biotechnology for Industrial Processing II-25
Marine Microbial Enzymes II-25
Marine-Derived Biopolymers & Biomaterials II-26
Marine Micro & Macro Algae II-27
Chitin & Chitosan II-27
Marine Bacteria II-28
Bioceramics II-28
Extremozymes II-28
Marine Biotechnology for Protecting Marine Ecosystems II-29
Biofouling II-29

Detecting Marine Pathogenic Organisms II-30
Bioremediation of Marine Ecosystems II-30
Marine Coatings Market II-30
Marine-Derived Pharmaceuticals II-31
Brief History II-31
Major Marine Sources for Drugs II-31
Applications of Marine Products in Pharmaceutical Industry II-32
Invertebrates - Major Focus of Research II-33
Marine Flora - Largely Unexplored II-33
Research Focus Entrenched on Marine Drugs II-33
FDA-Approved Marine Medicines by Therapeutic Category II-35
Robust Clinical Pipeline to Support Growth II-35
Select Marine-Derived Compounds in Phase I, II, III Clinical
Trials II-36
Anti-Cancer Drugs Dominate Drug Development Pipeline II-36
Anti-Cancer Marine Drugs in Clinical Trials II-37
Overview of FDA-Approved Anti-Tumor Drugs of Marine Origin II-38
PharmaMar: Undisputed Leader in Oncology Medicines of Marine
Origin II-38
PharmaMar's Clinical Pipeline of Marine-based Anti-Tumor Drugs II-39
Cardiovascular Marine Products II-39
Cardiovascular Marine Products by Marine Source II-39
An Overview of Select Cardiovascular Marine Products II-39
Key Challenges in Discovery of Marine-derived Drugs II-40

3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW II-41
Overview II-41
R&D Initiatives, Funding Programs & Research Priorities for
Marine Biotechnology II-42
The United States II-42
Canada II-43
Japan II-43
Europe II-43
Turkey II-44
Asia II-44
Australia & New Zealand II-44
China II-45
India II-45
South Korea II-45
Southeast Asia II-45
Latin America II-46
Middle East & Africa II-46
International Efforts in Marine Biotechnology Research II-46
Major R&D Projects in Marine Biotechnology Space II-47
EU Embarks on Ground-Breaking Marine Plankton Project II-47
KIOST Augments Research on Marine Biotechnology II-47
EU Launches BlueGenics Research Project II-47
Smithsonian Tropical Research Institute to Launch Global
Marine Biodiversity Project II-48

4. MARINE BIOTECHNOLOGY - AN OVERVIEW II-49
Prelude II-49
Significance of Marine Biodiversity II-49
Marine Biotechnology: Definition II-50
Why are Marine Organisms Crucial? II-50
Sources of Marine Biotech Products II-51
Key Marine Sources and Products II-51
Select Marine-Derived Products II-52
Marine Sponges II-52
Marine Plants II-52
Protista II-53
Marine Bacteria II-53
Marine Fungi II-53
Types of Marine Biotech Products II-53
Marine Biomaterials II-53
Marine Adhesives II-53
Marine Bioactive Substances II-54
Enzymes II-54
Haloperoxidase Enzymes II-54
Thermostable DNA-Modifying Enzymes II-54
Other Marine Products and Processes II-55
Marine Biomass II-55
Marine Bio-Process II-55
Significant Bio-Processes and their Applications II-55
End-Use Analysis II-55
Foods II-56
Nutraceuticals II-57
Medicine II-57
Cosmetics II-57

Research Tools II-57
Processing Technologies II-58
New Energy Sources II-58
Agriculture II-58
Industrial II-58
Food Safety II-59
Environmental Management II-59
Bioremediation II-59
Marine Biosurfactants II-59
Select Biosurfactants Produced from Marine Microorganisms II-60
Aquaculture and Marine Biotechnology II-60
Select Companies Carrying Out Genetic Enhancement or
Aquaculture Breeding Programs II-61
Industrial Applications II-61
Healthcare II-61
Select Marine Diterpenes and Their Biological Activity II-62
Select Players Involved in Biosensor/Diagnostic Activity II-62
Bioprospecting II-62
Select Companies Involved in Bioprospecting and Bioscreening
for Novel Marine- Based Compounds II-63

Consumer Products II-63
Select Macroalgal Materials and Applications in Cosmetic
Industry II-63
Public Services and Infrastructure II-63
Others II-64
An Insight into Select Marine-Origin Products II-64
Agar II-64
Major Seaweeds Used for Extracting Agar and Agarose II-64
Alginate II-65
Astaxanthin II-65
Select Producers of Natural and Synthetic Astaxanthin II-66
Carrageenan II-66
Chitin and Chitosan II-67
Chitin II-67
Chitosan II-67
Select Industrial Applications of Chitosan II-67
Collagen II-68
Salmon Calcitonin II-68

5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS II-69
New Research Finding Reveals the Role of Opisthobranchs in
Lignarenones Biosynthesis II-69
Norwegian Researchers Explore Potential of Tunicate as a
Source of Biofuel and Fish Feed II-69
Scientists Unearth Medicinal Properties of Marine Enzyme,
Bacillus Licheniformis II-70
Norwegian Researchers Study Potential of Farmed Salmon Waste
as Nutrients to Nourish Kelp and Mussel II-70
Researchers Study Effectiveness of Alginate Supplementation on
Weight Loss II-70
Lamellarins Can Stop Cancer Drug Resistance: New Finding on
Marine Natural Product II-71
Evaluation of DHA and EPA Concentration in Algal Species II-71
Study of Potential Applications of Delesseria Sanguinea II-72
Scientists Use Bacteria Occurring in Marine Waters to Develop
New Assays II-72

6. PRODUCT INTRODUCTIONS/INNOVATIONS II-73
Bluewave Marine Ingredients Launches AminoMarine™ Fish Protein
Powder II-73
Cyvex Nutrition Rolls Out Protomine™ Fish Protein Powder II-73
Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient II-73
Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging
Products II-73
DSM Unveils DHA plus EPA™ Product II-74
Aqua Bio Technology Launches New Marine-Based Ingredients II-74
La Prairie Launches Lifestyle Collection II-74
Aqua Bio Technology Launches Zonase X Marine Ingredient II-75
Frutarom USA to Introduce New Range of Marine Extracts II-75
Biotech Marine Launches BioFA Anti-Aging Ingredient II-76

7. RECENT INDUSTRY ACTIVITY II-77
FMC Snaps Up Epax II-77
Seppic Takes Over BiotechMarine II-77
Aker BioMarine Inks Agreement with BioMar Group II-77
NPC Inks Agreement with BASF II-78
Olympic Seafood Enters into Long-Term Licensing Agreement with
Aker BioMarine II-78
PharmaMar Teams with Costa Rican Experts II-78
Aqua Bio Technology Clinches Two Sales Contracts from a
Cosmetics Company II-79
PharmaMar Demonstrates New Clinical Trials with Four Marine-
Derived Anti-Tumor Drugs II-79
Stemtech International Inks Agreement with Marinova II-79
ABT Bags Multi Million Contract from Restorsea for
Aquabeautine XL™ Ingredient II-80
Aquapharm Collaborates with c-LEcta II-80
Aquapharm Joins Forces with Australian Institute of Marine

Science II-80
Aqua Bio Technology Signs Agreement with Amway II-80
Aquapharm Enters into Partnership with Aqua Bio Technology II-81
AE Biofuels Renames as Aemetis II-81
Jazz Pharmaceuticals Takes Over Azur Pharma II-81
DSM Acquires Martek II-81
Ashland Acquires ISP II-82
Aquapharm Strikes Agreement with Sederma II-82
Seattle Genetics Receives FDA Approval for Adcetris II-82
New England Biolabs Establishes New England Biolabs France II-83
Eisai Obtains FDA Clearance for Halaven, a Marine-Derived
Breast Cancer Drug II-83
Azur Pharma Acquires PRIALT® from Elan Pharmaceuticals II-83
Aqua Bio Technology Inks Supply Agreement with Bioforskning II-83
Aquapharm Biodiscovery Signs Licensing and Collaboration
Agreement with Croda II-84
AsiaPharm and GlycoMar Sign R&D Agreement II-84
Aquatic Eco-Systems Acquires Marine Biotech II-84
Dr. Reddy's Laboratories and Aquapharm Biodiscovery Ink
Licensing Agreements II-84
Aker BioMarine Merges with Natural ASA to Form Aker BioMarine II-84
Aker BioMarine Joins Hands with Pronova Biocare II-85
ABL Biotech to Establish New R&D Facility II-85
Aquapharm Strikes an Agreement with DowpharmaSM II-85
MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials
for NPI-0052 II-85
CP Kelco Acquires Gold Millet II-85
Oman's Attempt To Excel in Marine Research II-85
Marical Inks an Agreement with ACD II-86
PharmaMar Conducts Clinical Testing of Zalypsis ® Anti-tumor
Agent II-86

CP Kelco Merges with Noviant II-86
Marine Institute, Biotrove, and NUI'S Cooperative Research on
Atlantic Salmon II-86
Jinghua Marine Biological Merges with Work Recovery II-86
Albany Molecular Research and Alcon Research in Partnership II-87
Maryland-Israel Marine Biotechnology Research Program Gains
Extension II-87
India to Set Up New National Institutions II-87
European Centre for Marine Biotechnology Inaugurated II-87
Diversa Collaborates with OSU II-87
PharmaMar Commences Phase I Clinical Trials of PM02734 II-88
USFDA Confers Orphan Drug Status to PharmaMar's Ovarian Cancer
Drug, YONDELIS® II-88
PharmaMar Undertakes Phase II Clinical Trials of Aplidin® for
Bladder and Prostate Cancers II-88
CorMatrix and Cook Biotech Enter into Research Agreement II-88
Elan Corp Receives European Approval for PRIALT™ (Ziconotide) II-88

8. FOCUS ON SELECT PLAYERS II-89
Aker BioMarine AS (Norway) II-89
Aqua Bio Technology ASA (Norway) II-89
Aquapharm Biodiscovery Ltd (UK) II-89
CP Kelco (US) II-89
Cyanotech Corp. (US) II-90
Nutrex Hawaii (US) II-90
FMC Corp. (US) II-90
FMC BioPolymer (US) II-91

NovaMatrix (Norway) II-91
GlycoMar Ltd. (UK) II-91
Jazz Pharmaceuticals plc (Ireland) II-91
Lonza Group Ltd (Switzerland) II-92
Marinova Pty Ltd (Australia) II-92
New England Biolabs Inc (US) II-93
oceanBASIS GmbH (Germany) II-93
PharmaMar S.A (Spain) II-93
PML Applications Ltd. (UK) II-93
Prolume Ltd (US) II-94
BioLume®, Inc. (US) II-94
Pronova BioPharma ASA (Norway) II-94
Royal DSM N.V (Netherlands) II-95
Sea Run Holdings, Inc. (US) II-95
SEPPIC (France) II-96
Biotech Marine (France) II-96
Tequesta BioVentures (US) II-96

9. GLOBAL MARKET PERSPECTIVE II-97
Table 4: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-97

Table 5: World Historic Review for Marine Biotechnology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-98

Table 6: World 15-Year Perspective for Marine Biotechnology by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World

Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) II-99

Table 7: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Product Segment - Marine Biomaterials,
Marine Bioactive Substances, and Other Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-100

Table 8: World Historic Review for Marine Biotechnology by
Product Segment - Marine Biomaterials, Marine Bioactive
Substances, and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) II-101

Table 9: World 15-Year Perspective for Marine Biotechnology by
Product Segment - Percentage Breakdown of Dollar Sales for
Marine Biomaterials, Marine Bioactive Substances, and Other
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) II-102

Table 10: World Recent Past, Current & Future Analysis for
Marine Biotechnology by End-Use Application - Industrial
Products, Health Care/Biotechnology, Consumer Products, Public
Services & Infrastructure and Other Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-103

Table 11: World Historic Review for Marine Biotechnology by
End-Use Application - Industrial Products, Health
Care/Biotechnology, Consumer Products, Public Services &
Infrastructure and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) II-104

Table 12: World 15-Year Perspective for Marine Biotechnology
by End-Use Application - Percentage Breakdown of Dollar Sales
for Industrial Products, Health Care/Biotechnology, Consumer
Products, Public Services & Infrastructure and Other Markets
for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) II-105

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Overview III-1
Aquaculture Biotechnology III-1
Policy Framework to Offer Support for Marine Biotechnology III-1
Product Launches III-2
Strategic Corporate Developments III-3
Key Players III-5
B.Market Analytics III-8
Table 13: US Recent Past, Current & Future Analysis for
Marine Biotechnology Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-8

Table 14: US Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-9

2. CANADA III-10
Market Analysis III-10
Table 15: Canadian Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-10

Table 16: Canadian Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-11

3. JAPAN III-12
Market Analysis III-12
Table 17: Japanese Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-12

Table 18: Japanese Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-13

4. EUROPE III-14
A.Market Analysis III-14
Marine Biotechnology: Promising Opportunities for Europe III-14
A Nascent Yet Promising Market III-14
Marine and Algae Oils Market in Europe: An Overview III-15
Prospects for Blue Technology in Baltic Sea Region III-15
A Distinct Identity for Marine Biotechnology: The Way Forward III-16
Marine Drug Discovery: Need for Diversifying Research Focus III-16
Regulations Governing Marine Biotechnology in Europe III-16
A Glance at Key Documents & Events Focused on Marine
Biotechnology III-18
Initiatives for Marine Biotechnology Growth III-18
The European Commission Policies on Blue Technology (Marine
and Freshwater Biotechnology) III-20
Horizon 2020: Aiming for Faster Marketability of Innovations III-20
Focus on Select Regional Markets III-20
Belgium III-20

Denmark III-21
Germany III-21
North Germany Focuses on Maritime Resources III-21
Ireland III-21
Norway III-22
Overview III-22
Norway Leads in Bioprospecting Arctic Genetic Resources in
Nordic Countries III-22
Market Participants III-23
Industrial Applications III-23
Pharmaceuticals III-23
Norwegian Marine Biotechnology Companies III-23
Iceland III-25
Spain III-25
The United Kingdom III-25
Overview III-25
Role of Marine Algal Biomass in Energy Sector in UK III-26
Product Innovations/Introductions III-26
Strategic Corporate Developments III-28
Key Players III-32
B.Market Analytics III-37
Table 19: European Recent Past, Current & Future Analysis
for Marine Biotechnology Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-37

Table 20: European Historic Review for Marine Biotechnology
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-38

5. ASIA-PACIFIC III-39
A.Market Analysis III-39
Outlook III-39
Australia III-39
China III-39
India III-40
Marine Environment Offers Abundant Opportunities for R&D
Initiatives III-40
Biotechnology Market in India on a Growth Trajectory III-40
Government Initiatives III-41
New Zealand III-41
South Korea III-41
Strategic Corporate Developments III-42

Marinova Pty Ltd (Australia) - A Key Player III-43
B.Market Analytics III-43
Table 21: Asia-Pacific Recent Past, Current & Future
Analysis for Marine Biotechnology Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-43

Table 22: Asia-Pacific Historic Review for Marine
Biotechnology Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-44

6. REST OF WORLD III-45
A.Market Analysis III-45
Outlook III-45
Latin America III-45
Strategic Corporate Developments III-45
B.Market Analytics III-46
Table 23: Rest of World Recent Past, Current & Future
Analysis for Marine Biotechnology Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-46

Table 24: Rest of World Historic Review for Marine
Biotechnology Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-47

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 99 (including Divisions/Subsidiaries - 108)

The United States (29)
Canada (3)
Japan (2)
Europe (54)
- France (4)
- Germany (4)
- The United Kingdom (5)
- Spain (2)
- Rest of Europe (39)
Asia-Pacific (Excluding Japan) (17)
Latin America (1)
Middle East (2)